Kazuki Yoshida<p>Artificial intelligence in <a href="https://mastodon.social/tags/pharmacovigilance" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pharmacovigilance</span></a>: A regulatory perspective on explainability - Pinheiro - 2022 - <a href="https://mastodon.social/tags/Pharmacoepidemiology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Pharmacoepidemiology</span></a> and Drug Safety - Wiley Online Library</p><p><a href="https://onlinelibrary.wiley.com/doi/full/10.1002/pds.5524?campaign=woletoc" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">onlinelibrary.wiley.com/doi/fu</span><span class="invisible">ll/10.1002/pds.5524?campaign=woletoc</span></a></p>